Trial Profile
Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2012
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications Hepatitis D
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.